Entera Bio Appoints Gerald M. Ostrov to Board of Directors
January 10, 2019 07:00 ET
|
Entera Bio
JERUSALEM, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) announced today the appointment of Gerald M. Ostrov as a new independent director on its Board of Directors, effective...
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
December 11, 2018 07:00 ET
|
Entera Bio
Amgen will have the option to advance up to three large molecule programs using Entera’s oral delivery technology Entera will be eligible to receive up to $270 million in clinical and commercial...
Entera Bio Reports Positive Results from Part 1 of a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism
November 08, 2018 08:00 ET
|
Entera Bio
- - - Demonstrates positive results in three metabolic parameters in patients with hypoparathyroidism treated with Oral PTH (1-34) - - -Reports a significant decrease in 24-hour urinary calcium in...
Entera Bio Appoints Two New External Independent Members to the Board of Directors
October 02, 2018 08:00 ET
|
Entera Bio
JERUSALEM, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today the appointment of Faith L. Charles and Miranda J. Toledano to the company’s board of directors,...
Entera Bio Appoints Dr. Arthur Santora as Chief Medical Officer
September 21, 2018 09:15 ET
|
Entera Bio
JERUSALEM, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) today announced the appointment of Arthur C. Santora II, MD, PhD as its new Chief Medical Officer, effective...
Entera Bio Reports Second Quarter 2018 Financial Results and Operating Update
August 20, 2018 16:05 ET
|
Entera Bio
Closed Initial Public Offering on July 2, 2018Completed Part 1 of a Phase 2 PK/PD Study in Hypoparathyroidism Patients Mr. Gerald Lieberman was Appointed as Chairman of the Board of Directors ...
Entera Bio Ltd. Announces Appointment of Mr. Gerald Lieberman as Chairman of the Board of Directors
August 09, 2018 12:00 ET
|
Entera Bio
JERUSALEM, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX and ENTXW), announced today the appointment of Mr. Gerald Lieberman as the chairman of the board of directors, effective as...
Entera Bio Completes Part 1 of a Phase 2 PK/PD Study in Hypoparathyroidism Patients
August 01, 2018 08:00 ET
|
Entera Bio
A second and final part of the study will evaluate selected dose regimens chosen based on part 1 JERUSALEM, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), announced today that it...
Entera Bio Ltd. Announces Closing of Initial Public Offering
July 02, 2018 16:05 ET
|
Entera Bio
JERUSALEM, July 02, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally...
Entera Bio Ltd. Announces Pricing of Initial Public Offering
June 28, 2018 08:53 ET
|
Entera Bio
JERUSALEM, June 28, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally...